公开(公告)号：NO20041921A

公开(公告)日：2004-07-06

申请号：NO20041921

申请日：2004-05-10

Applicant: KANEKA CORP

Inventor： UEDA YASUYOSHI ,  MAE TATSUMASA ,  TSUKAGAWA MISUZU ,  KITAHARA MIKIO ,  NAKAGAWA KAKU ,  KITAMURA SHIRO ,  SAHIDA YUTAKA ,  KURODA MINPEI ,  MIMAKI YOSHIHIRO

IPC: A23K1/16 ,  A23K1/18 ,  A23L1/30 ,  A61K31/12 ,  A61K31/353 ,  A61K31/366 ,  A61K31/37 ,  A61K36/00 ,  A61K36/484 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P37/02 ,  A61P43/00 ,  C07D311/06 ,  C07D311/18 ,  C07D311/30 ,  C07D311/36 ,  C07D311/38 ,  C07D311/58 ,  C07D493/04 ,  A61K35/78

CPC classification number: C07D311/06 ,  A23K20/111 ,  A23K20/121 ,  A23K50/00 ,  A23K50/40 ,  A23L33/10 ,  A23L33/105 ,  A61K31/12 ,  A61K31/353 ,  A61K31/37 ,  A61K36/484 ,  A61K2300/00

公开(公告)号：NO20041921L

公开(公告)日：2004-07-06

申请号：NO20041921

申请日：2004-05-10

Applicant: KANEKA CORP

Inventor： UEDA YASUYOSHI ,  MAE TATSUMASA ,  TSUKAGAWA MISUZU ,  KITAHARA MIKIO ,  NAKAGAWA KAKU ,  KITAMURA SHIRO ,  SAHIDA YUTAKA ,  KURODA MINPEI ,  MIMAKI YOSHIHIRO

IPC: A23K1/16 ,  A23K1/18 ,  A23L1/30 ,  A61K31/12 ,  A61K31/353 ,  A61K31/366 ,  A61K31/37 ,  A61K36/00 ,  A61K36/484 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P37/02 ,  A61P43/00 ,  C07D311/06 ,  C07D311/18 ,  C07D311/30 ,  C07D311/36 ,  C07D311/38 ,  C07D311/58 ,  C07D493/04 ,  A61K35/78

Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.

公开(公告)号：NO20041921D0

公开(公告)日：2004-05-10

申请号：NO20041921

申请日：2004-05-10

Applicant: KANEKA CORP

Inventor： UEDA YASUYOSHI ,  MAE TATSUMASA ,  TSUKAGAWA MISUZU ,  KITAHARA MIKIO ,  NAKAGAWA KAKU ,  KITAMURA SHIRO ,  SAHIDA YUTAKA ,  KURODA MINPEI ,  MIMAKI YOSHIHIRO

IPC: A23K1/16 ,  A23K1/18 ,  A23L1/30 ,  A61K31/12 ,  A61K31/353 ,  A61K31/366 ,  A61K31/37 ,  A61K36/00 ,  A61K36/484 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P37/02 ,  A61P43/00 ,  C07D311/06 ,  C07D311/18 ,  C07D311/30 ,  C07D311/36 ,  C07D311/38 ,  C07D311/58 ,  C07D493/04 ,  A61K

Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.

公开(公告)号：CA2460134A1

公开(公告)日：2003-05-08

申请号：CA2460134

申请日：2002-10-11

Applicant: KANEKA CORP

Inventor： MAE TATSUMASA ,  UEDA YASUYOSHI ,  SASHIDA YUTAKA ,  NAKAGAWA KAKU ,  TSUKAGAWA MISUZU ,  KURODA MINPEI ,  MIMAKI YOSHIHIRO ,  KITAHARA MIKIO ,  KITAMURA SHIRO

IPC: A23K1/16 ,  A23K1/18 ,  A23L1/30 ,  A61K31/12 ,  A61K31/353 ,  A61K31/366 ,  A61K31/37 ,  A61K36/00 ,  A61K36/484 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P37/02 ,  A61P43/00 ,  C07D311/06 ,  C07D311/18 ,  C07D311/30 ,  C07D311/36 ,  C07D311/38 ,  C07D311/58 ,  C07D493/04 ,  A61K35/78

Abstract: It is intended to conveniently and effectively provide peroxisome proliferat or activated ligands and compositions containing the same as the active ingredient for improving insulin resistance or preventing and/or relieving insulin resistance syndrome. Peroxisome proliferator activated ligands which comprise prenyl flavonoid, flavonol derivatives other than prenyl flavonoid, chalcone derivatives other than prenyl flavonoid, or salts, glycosides and/or esters thereof which are accepted as medicines, foods or drinks; composition s containing these ligands; extracts originating in plants containing these ligands; and a process for producing such extract.

公开(公告)号：EP1440688A4

公开(公告)日：2005-11-30

申请号：EP02802360

申请日：2002-10-11

Applicant: KANEKA CORP

Inventor： MAE TATSUMASA ,  TSUKAGAWA MISUZU ,  KITAHARA MIKIO ,  NAKAGAWA KAKU ,  KITAMURA SHIRO ,  UEDA YASUYOSHI ,  KURODA MINPEI ,  MIMAKI YOSHIHIRO ,  SASHIDA YUTAKA

IPC: A23K1/16 ,  A23K1/18 ,  A23L1/30 ,  A61K31/12 ,  A61K31/353 ,  A61K31/366 ,  A61K31/37 ,  A61K36/00 ,  A61K36/484 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P37/02 ,  A61P43/00 ,  C07D311/06 ,  C07D311/18 ,  C07D311/30 ,  C07D311/36 ,  C07D311/38 ,  C07D311/58 ,  C07D493/04 ,  A61K35/78 ,  A61P29/00 ,  A61P35/00

CPC classification number: C07D311/06 ,  A23K20/111 ,  A23K20/121 ,  A23K50/00 ,  A23K50/40 ,  A23L33/10 ,  A23L33/105 ,  A61K31/12 ,  A61K31/353 ,  A61K31/37 ,  A61K36/484 ,  A61K2300/00

Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.